| |
| |
|
| Insider
Information: |
Behan Dominic P |
| Relationship: |
EVP & Chief Scientific... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
508,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$50,794,920 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
508,000 |
|
|
| Total
Value |
$50,794,920 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arena Pharmaceuticals Inc |
ARNA |
EVP & Chief Scientific... |
2014-12-15 |
508,000 |
2006-01-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARNA |
Arena Pharmaceuticals Inc |
EVP & Chief Scientific Officer |
• • – |
2014-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
508,000 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
EVP & Chief Scientific Officer |
• • – |
2014-01-10 |
4 |
AS |
$6.25 |
$208,325 |
D/D |
(33,332) |
483,000 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
EVP & Chief Scientific Officer |
• • – |
2014-01-10 |
4 |
OE |
$6.00 |
$199,992 |
D/D |
33,332 |
516,332 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
EVP & Chief Scientific Officer |
• • – |
2013-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
483,000 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
EVP & Chief Scientific Officer |
• • – |
2013-09-10 |
4 |
AS |
$6.31 |
$1,261,020 |
D/D |
(200,000) |
453,000 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
EVP & Chief Scientific Officer |
• • – |
2013-09-10 |
4 |
OE |
$1.49 |
$314,000 |
D/D |
200,000 |
653,000 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
EVP & Chief Scientific Officer |
• • – |
2012-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
453,000 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
SVP & Chief Scientific Officer |
• • – |
2010-01-28 |
4 |
OE |
$0.60 |
$16,500 |
D/D |
27,500 |
423,000 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
SVP & Chief Scientific Officer |
• • – |
2009-02-09 |
4 |
OE |
$0.60 |
$36,000 |
D/D |
60,000 |
395,500 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
SVP & Chief Scientific Officer |
• • – |
2007-12-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,000 |
335,500 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
SVP & Chief Scientific Officer |
• • – |
2007-03-20 |
4 |
OE |
$0.60 |
$15,000 |
D/D |
25,000 |
342,500 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
SVP & Chief Scientific Officer |
• • – |
2007-03-15 |
4 |
AS |
$11.15 |
$655,876 |
D/D |
(58,552) |
317,500 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
SVP & Chief Scientific Officer |
• • – |
2007-03-15 |
4 |
OE |
$6.00 |
$204,013 |
D/D |
33,552 |
376,052 |
0 |
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
officerTitle |
• • – |
2006-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
343,750 |
|
- |
|
| ARNA |
Arena Pharmaceuticals Inc |
SVP & Chief Scientific Officer |
• • – |
2001-04-30 |
5 |
AS |
$19.59 |
$24,488 |
D/D |
(1,250) |
317,500 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
